CSSi Blogs

Rebuilding Trust in Clinical Trials: Diverse Patient Recruitment

  • By Myra Zerr-Korolev
  • 03-Aug-2021

image of diversity in our general population in America today

The health and well-being of all persons regardless of race, religion, sexual orientation, or gender is integral to public health. As a nation, the United States is slowly improving and becoming self-aware of the maladaptive behavior towards its minority citizens both past and present. Notably, BIPOC (Black, Indigenous, Person of Color) members of society have a history of fear and distrust due to poor, unethical, neglectful, and even cruel treatment received from medical and governmental research organizations1, 2, 3.

What can we do to successfully recruit patients from the BIPOC community when there are so many lingering issues that need to be addressed?

Let’s first look toward recognizing and acknowledging the concerns of the BIPOC patient. This could look like addressing concerns, understanding cultural differences and significances, and initiating productive discussions. Bridging the gap between the medical research community and minority populations is not a simple check list or a one-size fits all solution.

When interacting with different populations, whether it be African American, Asian, Latinx, Indigenous or other BIPOC peoples, it is absolutely integral to dive into the identity and culture of the community. Identities and cultures have been neglected in the past, causing communities to push against participating in healthcare systems. The needs of each community can differ from each other, though there are common parallels that can be useful to provide each group.

Several communities don’t trust the efficacy of health care (and its providers) or the science that backs it. This sort of trust is built by continued dialogue, outreach education efforts, and partnering with community leaders. Partnering and collaborating with all communities regardless of type of research, rather than strictly analyzing and doing research on the community, provides these patients autonomy, confidence, and the initial seeds of trust.

If we wish to truly incorporate and recruit patients within the BIPOC community, we must implement trust rebuilding strategies around respect, collaboration, and relationship development. CPPR, or Community Partnered Participatory Research, is an approach that addresses the needs of each individual community4. By using this method, we can begin and maintain an equitable partnership between ourselves and diverse communities. CPPR uses community partnership to develop research, implement that research and disseminate research results to the community.

What sort of steps can we make when looking toward the CPPR, ethical SOPs and cultural relativity for guidance?

We can:

  • •     Recognize communities as units of identity
  • •     Build on the already established strength, resources, and trusted members of communities
  • •     Facilitate collaborative partnerships with community organizations
  • •     Promote co-learning and education
  • •     Bring a balance of passive research and action for all who are affected by the research
  • •     Focus on and inform communities about relevant public health problems
  • •     Create, maintain, and update ethical research SOPs consistently
  • •     Share the research knowledge gained to all community organizations
  • •     Establish a long-term commitment to the process (continue building relationships with communities even after termination of research)

By implementing and building on certain equitable methods and concepts (as again, nothing is one-size fits all, each community will have different needs and concerns), treatment and recruitment is a duty that we ALL must undertake. Building trust and relationships is slow, but necessary, process. We need to ensure true equability and equality in ALL demographic populations, as each population is an important piece of the mosaic that is our healthcare and global community.

Citations:

1 Braunstein JB, Sherber NS, Schulman SP, Ding EL, Powe NR. Race, medical researcher distrust, perceived harm, and willingness to participate in cardiovascular prevention trials. Medicine (Baltimore). 2008 Jan;87(1):1-9. doi: 10.1097/MD.0b013e3181625d78. PMID: 18204365.

2 Whitesell NR, Mousseau A, Parker M, Rasmus S, Allen J. Promising Practices for Promoting Health Equity Through Rigorous Intervention Science with Indigenous Communities. Prev Sci. 2020;21(Suppl 1):5-12. doi:10.1007/s11121-018-0954-x

3 Hong, Y.‐R., Tauscher, J. and Cardel, M. (2018), Distrust in health care and cultural factors are associated with uptake of colorectal cancer screening in Hispanic and Asian Americans. Cancer, 124: 335-345. https://doi.org/10.1002/cncr.31052

4 Sankaré, I. C., Bross, R., Brown, A. F., Del Pino, H. E., Jones, L. F., Morris, D. M., . . . Kahn, K. L. (2015). Strategies to build trust and Recruit African American and Latino community residents for Health research: A cohort study. Clinical and Translational Science, 8(5), 412-420. doi:10.1111/cts.12273

 

Follow us!

 

Image of diversity in our general population in America today.

Rebuilding Trust in Clinical Trials: Diverse Patient Recruitment

  • By Myra Zerr-Korolev
  • 03-Aug-2021

The health and well-being of all persons regardless of race, religion, sexual orientation, or gender is integral to public health. As a nation, the United States is slowly improving and becoming self-aware of the maladaptive behavior towards its minority citizens both past and present.

Read More
Image of Study Coordinator and Patient reviewing considerations for study trial.

Post-COVID-19 Patient Recruitment: Dealing with the Aftermath

  • By Myra Zerr-Korolev
  • 02-Jun-2021

Clinical trial recruitment has been understandingly difficult for the past fifteen months. Isolation and quarantine have kept patients (not to mention site and trial staff) from being able to undergo appropriate screening and enrollment measures. Because of this immense issue, many trials have been paused (or worse, stopped all together).

Read More
image of doctors office nurse performing a telephone chart review.

The 24-Hour Window: Responding to Your Referrals Before They Lose Interest

  • By Gabrielle St Remy
  • 03-Sep-2020

Patient recruitment is often a time-consuming and high-cost step in completing your clinical trials. Your marketing team will have to develop the correct study message and a strong call-to-action to get people motivated to see if they prequalify. You must strategically target your patient population and generate interest in participation among this audience.

Read More
image of LES performing a telephone chart review.

Recruiting for Trials During a Global Pandemic

  • By Gabrielle St Remy
  • 16-Apr-2020

The COVID-19 virus has significantly changed the way the world operates. It has caused unprecedented interruptions to many industries and businesses around the globe, and clinical trials are no exception. New guidelines have been issued by the FDA regarding clinical trials, which could have a significant impact on study enrollment and patient retention.

Read More
image of plnning for Multichannel Marketing

Don’t Put All Your Recruitment Eggs in One Basket

  • By Gabrielle St Remy
  • 12-Mar-2020

As you begin the patient recruitment process for your study, it can be tempting to put all of your money towards one method. You place all bets on digital advertising because that generated the most referrals during your last study. What happens if digital doesn’t perform for you this time? It’s best to spread your advertising budget out over a number of recruitment methods. This gives you the ability to truly test what is most effective.

Read More
image of divers people

Answering the Lack of Diversity in Clinical Trials

  • By Gabrielle St Remy
  • 15-Nov-2019

Identifying and implementing ways to increase diversity in clinical trials is a growing topic in the industry. Almost 40 percent of Americans belong to a racial or ethnic minority, but roughly 80-90 percent of participants in clinical trials for new drugs are still disproportionately Caucasian.1

In order to make sure drugs and treatments are safe and reliable to all people, there needs to be a better representation

Read More
image of a woman comparing streaming app on her phone and computer

New Advertising Options for Patient Recruitment: Are they on your radar?

  • By Gabrielle St Remy
  • 29-Aug-2019

We all see others do it, and we probably experience it ourselves it every day.

Watching videos and tv shows on devices other than the TV in the family room, catching up on your favorite sitcom on-demand because you weren't home to watch it at 8pm when it originally aired, or streaming videos on YouTube to pass time. As the years go by, technology and media are changing – and so is how we are using them.

Read More
image of a woman reviewing app on her phone

Understanding & Removing the Barriers to Patient Retention

  • By Gabrielle St Remy
  • 14-Aug-2019

Each year, $1.89 billion is spent on patient recruitment for clinical trials.1 With a 30% average dropout rate across all clinical trials, many pharmaceutical companies are spending a large amount of money to recruit patients who aren't staying enrolled in their trials.

Needed study data for regulatory submission and the overall success of a clinical trial depend largely on study participants fulfilling their roles and responsibilities until the very last day.

Read More
images of 14 Years in Service

CSSi Celebrates 14 Years as a Full-Service Patient Recruitment Agency

  • By Gabrielle St Remy
  • 11-Apr-2019

As a sponsor, CRO or site, there are a surplus of patient recruitment companies you can turn to when you need help finding patients for your studies, and that number grows higher every day. Most of these companies offer a niche service, but very few are a full-service, global recruitment agency like ours.

Read More
images of digital advertizing

Traditional Advertising Is Still Alive

  • By Gabrielle St Remy
  • 01-Apr-2019

We've all heard it before: "traditional advertising is dead." But if that were true, why are we still seeing commercials on TV, hearing ads on the radio, and seeing billboards on the highway during our morning commute?

Because it's not true! Traditional advertising is still very much alive and used by some of the largest companies worldwide.

Read More
images of responsive design with websites

Eight-Step Guide to a Strong Clinical Trial Website

  • By Gabrielle St Remy
  • 05-Feb-2019

There are about 93 million Americans searching online for information related to a health-related topic, with 63% of those individuals looking up a specific disease or medical problem. In fact, looking for health or medical information comes high on the list as one of the most popular activities people do when they are

Read More
person working on logo design

Clinical Trial Branding: Why is it so Important?

  • By Clara Hughes, Creative Director
  • 25-Jan-2019

Let's imagine two different scenarios:
A: You're sitting in a doctor's office, and you see a poster for ACN-053-2414, a clinical trial testing medication for acne in adults.
B: You're sitting in a doctor's office, and you see a poster for the Face It Acne Research Study, a clinical trial testing medication for acne in adults.

Read More